IMI 2 commits EUR 95M to new call for proposals

The EU's Innovative Medicines Initiative issued its fifth call for proposals for its IMI 2 program with a budget of EUR 95 million ($105.3 million). The program is soliciting proposals in six research areas, four of which focus on Alzheimer's disease.

The AD projects include programs involving two proteins, triggering receptor expressed on myeloid cells 2 ( TREM2) and CD33, to affect inflammation and AD risk; amyloid imaging biomarkers; patient engagement and early intervention; and apolipoprotein E ( APOE) biology. In March, IMI launched a joint Alzheimer's Disease Research Platform with a budget of EUR 138 million ($145.3 million) (see BioCentury Extra, March 19). ...